26 septiembre 2015
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma, a patient population for whom treatment options are currently limited.
http://www.sciencedaily.com/releases/2015/09/150926191754.htm
